Cycloalkyl-diamines for the treatment of inflammation
US11426411B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2020 |
| Grant date | Aug 30, 2022 |
| Priority date | — |
| Expiry date | Apr 27, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4965
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method of treatment for inflammation in mammals including inflammation caused by bacterial or viral infection, the method comprising administering to a mammal, including a human, in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.